These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 24704720)

  • 1. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
    Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
    Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Loss of SMAD4 from colorectal cancer cells promotes CCL15 expression to recruit CCR1+ myeloid cells and facilitate liver metastasis.
    Itatani Y; Kawada K; Fujishita T; Kakizaki F; Hirai H; Matsumoto T; Iwamoto M; Inamoto S; Hatano E; Hasegawa S; Maekawa T; Uemoto S; Sakai Y; Taketo MM
    Gastroenterology; 2013 Nov; 145(5):1064-1075.e11. PubMed ID: 23891973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
    Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
    Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimetastatic role of Smad4 signaling in colorectal cancer.
    Zhang B; Halder SK; Kashikar ND; Cho YJ; Datta A; Gorden DL; Datta PK
    Gastroenterology; 2010 Mar; 138(3):969-80.e1-3. PubMed ID: 19909744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Smad4-mediated signaling inhibits intestinal neoplasia by inhibiting expression of β-catenin.
    Freeman TJ; Smith JJ; Chen X; Washington MK; Roland JT; Means AL; Eschrich SA; Yeatman TJ; Deane NG; Beauchamp RD
    Gastroenterology; 2012 Mar; 142(3):562-571.e2. PubMed ID: 22115830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The bone morphogenetic protein pathway is active in human colon adenomas and inactivated in colorectal cancer.
    Kodach LL; Bleuming SA; Musler AR; Peppelenbosch MP; Hommes DW; van den Brink GR; van Noesel CJ; Offerhaus GJ; Hardwick JC
    Cancer; 2008 Jan; 112(2):300-6. PubMed ID: 18008360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of bone morphogenetic protein 4 enhances the invasiveness of Smad4-deficient human colorectal cancer cells.
    Deng H; Ravikumar TS; Yang WL
    Cancer Lett; 2009 Aug; 281(2):220-31. PubMed ID: 19321257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The bone morphogenetic protein pathway is inactivated in the majority of sporadic colorectal cancers.
    Kodach LL; Wiercinska E; de Miranda NF; Bleuming SA; Musler AR; Peppelenbosch MP; Dekker E; van den Brink GR; van Noesel CJ; Morreau H; Hommes DW; Ten Dijke P; Offerhaus GJ; Hardwick JC
    Gastroenterology; 2008 May; 134(5):1332-41. PubMed ID: 18471510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway.
    Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC
    Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Cichoric Acid on Colorectal Cancer: Impact on Migration, Epithelial-Mesenchymal Transition, and Proliferation
    Ma S; Huang Z; Chen Q; Yin X
    Discov Med; 2024 Jan; 36(180):190-198. PubMed ID: 38273759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC.
    Voorneveld PW; Kodach LL; Jacobs RJ; van Noesel CJ; Peppelenbosch MP; Korkmaz KS; Molendijk I; Dekker E; Morreau H; van Pelt GW; Tollenaar RA; Mesker W; Hawinkels LJ; Paauwe M; Verspaget HW; Geraets DT; Hommes DW; Offerhaus GJ; van den Brink GR; Ten Dijke P; Hardwick JC
    Br J Cancer; 2015 Jan; 112(1):122-30. PubMed ID: 25393365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the ERK pathway reduces liver metastasis of Smad4-inactivated colorectal cancer.
    Ai X; Wu Y; Zhang W; Zhang Z; Jin G; Zhao J; Yu J; Lin Y; Zhang W; Liang H; Datta PK; Zhang M; Zhang B; Chen X
    Cancer Biol Ther; 2013 Nov; 14(11):1059-67. PubMed ID: 24025354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
    Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
    Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-20a-5p promotes colorectal cancer invasion and metastasis by downregulating Smad4.
    Cheng D; Zhao S; Tang H; Zhang D; Sun H; Yu F; Jiang W; Yue B; Wang J; Zhang M; Yu Y; Liu X; Sun X; Zhou Z; Qin X; Zhang X; Yan D; Wen Y; Peng Z
    Oncotarget; 2016 Jul; 7(29):45199-45213. PubMed ID: 27286257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of SMAD4 Promotes Lung Metastasis of Colorectal Cancer by Accumulation of CCR1+ Tumor-Associated Neutrophils through CCL15-CCR1 Axis.
    Yamamoto T; Kawada K; Itatani Y; Inamoto S; Okamura R; Iwamoto M; Miyamoto E; Chen-Yoshikawa TF; Hirai H; Hasegawa S; Date H; Taketo MM; Sakai Y
    Clin Cancer Res; 2017 Feb; 23(3):833-844. PubMed ID: 27492974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic protein signaling and growth suppression in colon cancer.
    Beck SE; Jung BH; Fiorino A; Gomez J; Rosario ED; Cabrera BL; Huang SC; Chow JY; Carethers JM
    Am J Physiol Gastrointest Liver Physiol; 2006 Jul; 291(1):G135-45. PubMed ID: 16769811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of Smad4 in colorectal cancer induces resistance to 5-fluorouracil through activating Akt pathway.
    Zhang B; Zhang B; Chen X; Bae S; Singh K; Washington MK; Datta PK
    Br J Cancer; 2014 Feb; 110(4):946-57. PubMed ID: 24384683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.